The β-chain of cell surface F0F1 ATPase modulates ApoA-I and HDL transcytosis through aortic endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 1, 2012, Pages 131-139

  Cavelier, Clara ^a   Ohnsorg, Pascale M ^a,b,c   Rohrer, Lucia ^a,c   Von Eckardstein, Arnold ^a,c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Life Science Zurich   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

apolipoproteins; endothelium; F 0F 1 ATPase; lipoproteins; transcytosis

Indexed keywords

ABC TRANSPORTER A1; ABC TRANSPORTER G1; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PURINERGIC P2Y12 RECEPTOR; SCAVENGER RECEPTOR BI;

ANIMAL CELL; ARTICLE; BETA CHAIN; BIOTINYLATION; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME BINDING; GENE SILENCING; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RNA INTERFERENCE; TRANSCYTOSIS; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

ADENOSINE DIPHOSPHATE; ANIMALS; ANTIGENS, CD36; AORTA; APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; BASE SEQUENCE; CATTLE; CELL MEMBRANE; CELLS, CULTURED; ENDOCYTOSIS; ENDOTHELIAL CELLS; LIPOPROTEINS, HDL; MODELS, BIOLOGICAL; PROTON-TRANSLOCATING ATPASES; RECEPTORS, PURINERGIC P2Y12; RNA, SMALL INTERFERING; TRANSCYTOSIS;

EID: 83655167244     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.238063     Document Type: Article

References (41)

1. von Eckardstein A, Rohrer L. Transendothelial lipoprotein transport and regulation of endothelial permeability and integrity by lipoproteins. Curr Opin Lipidol. 2009;20:197-205.
2. Lindstedt L, Lee M, Castro GR, Fruchart JC, Kovanen PT. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein A-I-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid. J Clin Invest. 1996;97: 2174-2182. (Pubitemid 26165707)
3. Jaspard B, Fournier N, Vieitez G, Atger V, Barbaras R, Vieu C, Manent J, Chap H, Perret B, Collet X. Structural and functional comparison of HDL from homologous human plasma and follicular fluid. A model for extravascular fluid. Arterioscler Thromb Vasc Biol. 1997;17:1605-1613. (Pubitemid 27387784)
4. Nanjee MN, Cooke CJ, Olszewski WL, Miller NE. Concentrations of electrophoretic and size subclasses of apolipoprotein A-I-containing particles in human peripheral lymph. Arterioscler Thromb Vasc Biol. 2000; 20:2148-2155.
5. Asztalos BF, Sloop CH, Wong L, Roheim PS. Comparison of apo A-Icontaining subpopulations of dog plasma and prenodal peripheral lymph: evidence for alteration in subpopulations in the interstitial space. Biochim Biophys Acta. 1993;1169:301-304. (Pubitemid 23264887)
6. Rohrer L, Cavelier C, Fuchs S, Schluter MA, Volker W, von Eckardstein A. Binding, internalization and transport of apolipoprotein A-I by vascular endothelial cells. Biochim Biophys Acta. 2006;1761:186-194.
7. Cavelier C, Rohrer L, von Eckardstein A. ATP-binding cassette transporter A1 modulates apolipoprotein A-I transcytosis through aortic endothelial cells. Circ Res. 2006;99:1060-1066. (Pubitemid 44729929)
8. Rohrer L, Ohnsorg PM, Lehner M, Landolt F, Rinninger F, von Eckardstein A. High-density lipoprotein transport through aortic endothelial cells involves scavenger receptor BI and ATP-binding cassette transporter G1. Circ Res. 2009;104:1142-1150.
9. Ohnsorg PM, Rohrer L, Perisa D, Kateifides A, Chroni A, Kardassis D, Zannis VI, von Eckardstein A. Carboxyl terminus of apolipoprotein A-I (apoA-I) is necessary for the transport of lipid-free apoA-I but not prelipidated apoA-I particles through aortic endothelial cells. J Biol Chem. 2011;286:7744-7754.
10. Martinez LO, Jacquet S, Esteve JP, Rolland C, Cabezon E, Champagne E, Pineau T, Georgeaud V, Walker JE, Terce F, Collet X, Perret B, Barbaras R. Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature. 2003;421:75-79. (Pubitemid 36077087)
11. Boyer PD. The ATP synthase: a splendid molecular machine. Annu Rev Biochem. 1997;66:717-749. (Pubitemid 27274672)
12. Wittig I, Schagger H. Structural organization of mitochondrial ATP synthase. Biochim Biophys Acta. 2008;1777:592-598.
13. Das B, Mondragon MO, Sadeghian M, Hatcher VB, Norin AJ. A novel ligand in lymphocyte-mediated cytotoxicity: Expression of the beta subunit of H+transporting ATP synthase on the surface of tumor cell lines. J Exp Med. 1994;180:273-281. (Pubitemid 24181076)
14. Moser TL, Stack MS, Asplin I, Enghild JJ, Hojrup P, Everitt L, Hubchak S, Schnaper HW, Pizzo SV. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA. 1999;96: 2811-2816. (Pubitemid 29148800)
15. Kim BW, Choo HJ, Lee JW, Kim JH, Ko YG. Extracellular ATP is generated by ATP synthase complex in adipocyte lipid rafts. Exp Mol Med. 2004;36:476-485.
16. Scotet E, Martinez LO, Grant E, Barbaras R, Jeno P, Guiraud M, Monsarrat B, Saulquin X, Maillet S, Esteve JP, Lopez F, Perret B, Collet X, Bonneville M, Champagne E. Tumor recognition following vgamma9vdelta2 T cell receptor interactions with a surface F1-ATPaserelated structure and apolipoprotein A-I. Immunity. 2005;22:71-80. (Pubitemid 40143452)
17. Giorgio V, Bisetto E, Franca R, Harris DA, Passamonti S, Lippe G. The ectopic F(o)F(1) ATP synthase of rat liver is modulated in acute cholestasis by the inhibitor protein IF1. J Bioenerg Biomembr. 2010;42: 117-123.
18. Soltys BJ, Gupta RS. Mitochondrial-matrix proteins at unexpected locations: Are they exported? Trends Biochem Sci. 1999;24:174-177. (Pubitemid 29348446)
19. Wahl ML, Kenan DJ, Gonzalez-Gronow M, Pizzo SV. Angiostatin's molecular mechanism: Aspects of specificity and regulation elucidated. J Cell Biochem. 2005;96:242-261. (Pubitemid 41437858)
20. Champagne E, Martinez LO, Collet X, Barbaras R. Ecto-f1fo ATP synthase/f1 ATPase: metabolic and immunological functions. Curr Opin Lipidol. 2006;17:279-284. (Pubitemid 43786062)
21. Chi SL, Pizzo SV. Cell surface F1F0 ATP synthase: A new paradigm? Ann Med. 2006;38:429-438. (Pubitemid 44484880)
22. Mangiullo R, Gnoni A, Leone A, Gnoni GV, Papa S, Zanotti F. Structural and functional characterization of F(o)F(1)-ATP synthase on the extracellular surface of rat hepatocytes. Biochim Biophys Acta. 2008;1777: 1326-1335.
23. Lyly A, Marjavaara SK, Kyttala A, Uusi-Rauva K, Luiro K, Kopra O, Martinez LO, Tanhuanpaa K, Kalkkinen N, Suomalainen A, Jauhiainen M, Jalanko A. Deficiency of the INCL protein Ppt1 results in changes in ectopic F1-ATP synthase and altered cholesterol metabolism. Hum Mol Genet. 2008;17:1406-1417. (Pubitemid 351627337)
24. Jacquet S, Malaval C, Martinez LO, Sak K, Rolland C, Perez C, Nauze M, Champagne E, Terce F, Gachet C, Perret B, Collet X, Boeynaems JM, Barbaras R. The nucleotide receptor P2Y13 is a key regulator of hepatic high-density lipoprotein (HDL) endocytosis. Cell Mol Life Sci. 2005;62: 2508-2515. (Pubitemid 41801103)
25. Malaval C, Laffargue M, Barbaras R, Rolland C, Peres C, Champagne E, Perret B, Terce F, Collet X, Martinez LO. RhoA/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes. Cell Signal. 2009;21:120-127.
26. Wang L, Karlsson L, Moses S, Hultgardh-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S, Erlinge D. P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol. 2002;40:841-853. (Pubitemid 35365082)
27. Shen J, DiCorleto PE. ADP stimulates human endothelial cell migration via P2Y1 nucleotide receptor-mediated mitogen-activated protein kinase pathways. Circ Res. 2008;102:448-456. (Pubitemid 351651109)
28. Shanker G, Kontos JL, Eckman DM, Wesley-Farrington D, Sane DC. Nicotine upregulates the expression of P2Y12 on vascular cells and megakaryoblasts. J Thromb Thrombolysis. 2006;22:213-220. (Pubitemid 44857783)
29. Moser TL, Kenan DJ, Ashley TA, Roy JA, Goodman MD, Misra UK, Cheek DJ, Pizzo SV. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA. 2001;98:6656-6661. (Pubitemid 32538272)
30. Radojkovic C, Genoux A, Pons V, Combes G, de Jonge H, Champagne E, Rolland C, Perret B, Collet X, Terce F, Martinez LO. Stimulation of cell surface F1-ATPase activity by apolipoprotein A-I inhibits endothelial cell apoptosis and promotes proliferation. Arterioscler Thromb Vasc Biol. 2009;29:1125-1130.
31. Pullman ME, Monroy GC. A naturally occurring inhibitor of mitochondrial adenosine triphosphatase. J Biol Chem. 1963;238:3762-3769.
32. Rouslin W. Regulation of the mitochondrial ATPase in situ in cardiac muscle: Role of the inhibitor subunit. J Bioenerg Biomembr. 1991;23: 873-888.
33. Howard AD, Verghese PB, Arrese EL, Soulages JL. The beta-subunit of ATP synthase is involved in cellular uptake and resecretion of apoA-I but does not control apoA-I-induced lipid efflux in adipocytes. Mol Cell Biochem. 2011;348:155-164.
34. Osanai T, Magota K, Tanaka M, Shimada M, Murakami R, Sasaki S, Tomita H, Maeda N, Okumura K. Intracellular signaling for vasoconstrictor coupling factor 6: Novel function of beta-subunit of ATP synthase as receptor. Hypertension. 2005;46:1140-1146. (Pubitemid 41533017)
35. Seye CI, Yu N, Gonzalez FA, Erb L, Weisman GA. The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (kdr/flk-1). J Biol Chem. 2004;279: 35679-35686. (Pubitemid 39100571)
36. Fabre AC, Malaval C, Ben Addi A, Verdier C, Pons V, Serhan N, Lichtenstein L, Combes G, Huby T, Briand F, Collet X, Nijstad N, Tietge UJ, Robaye B, Perret B, Boeynaems JM, Martinez LO. P2Y13 receptor is critical for reverse cholesterol transport. Hepatology. 2010;52: 1477-1483.
37. Tanaka N, Kawasaki K, Nejime N, Kubota Y, Nakamura K, Kunitomo M, Takahashi K, Hashimoto M, Shinozuka K. P2Y receptor-mediated Ca(2+) signaling increases human vascular endothelial cell permeability. J Pharmacol Sci. 2004;95:174-180. (Pubitemid 38899686)
38. Tanaka N, Nejime N, Kagota S, Kubota Y, Yudo K, Nakamura K, Kunitomo M, Takahashi K, Hashimoto M, Shinozuka K. ATP participates in the regulation of microvessel permeability. J Pharm Pharmacol. 2006;58:481-487.
39. Abbracchio MP, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Miras-Portugal MT, King BF, Gachet C, Jacobson KA, Weisman GA, Burnstock G. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci. 2003;24:52-55. (Pubitemid 36135872)
40. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, Weisman GA. International union of pharmacology lviii: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev. 2006;58:281-341. (Pubitemid 44394905)
41. Soulet C, Sauzeau V, Plantavid M, Herbert JM, Pacaud P, Payrastre B, Savi P. Gi-dependent and-independent mechanisms downstream of the P2Y12 ADP-receptor. J Thromb Haemost. 2004;2:135-146. (Pubitemid 40185630)